- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.11. | Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs | ||
| 06.11. | AstraZeneca CEO: 'We can absorb the impact' of drug pricing deal with Trump | ||
| 06.11. | Incyte expands awards program to hidradenitis suppurativa ahead of FDA filing | ||
| 06.11. | Cencora earmarks $1B to expand US drug distribution operations | ||
| 05.11. | Supernus pauses new patient starts for Parkinson's pump Onapgo, citing high demand | ||
| 05.11. | Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter | ||
| 05.11. | Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive | ||
| 05.11. | Madrigal reports sales boost for Rezdiffra while welcoming Novo to MASH market | ||
| 05.11. | AstraZeneca adds $136M investment to Chinese inhalants plant | ||
| 05.11. | After shaky Q3, Novo's new CEO says company's diabetes and obesity turnaround is a 'marathon, not a sprint' | ||
| 05.11. | With sales booming, Amgen wants US biosimilar landscape to remain as is | ||
| 04.11. | Lilly, Novo Nordisk in pricing, coverage talks with Trump administration on obesity meds: Endpoints | ||
| 04.11. | Pfizer's Prevnar, Abrysvo and Comirnaty suffer Q3 sales declines amid tough US market for vaccines | ||
| 04.11. | Lilly signs on as 2026 Milan Olympics sponsor, re-ups donations for each Team USA win | ||
| 04.11. | Publisher's note: Questex acquisition supercharges Fierce portfolio with The Conference Forum, Versalinx Global Events | ||
| 04.11. | On a roll, UCB picks up another rare disease FDA approval | ||
| 04.11. | Arcutis taps '90210' star power to spell out the needs of people with skin conditions | ||
| 04.11. | Insulet campaign takes aim at workplace challenges for people with diabetes | ||
| 04.11. | Teva recalls more than half-a-million bottles of blood pressure drug over potential carcinogens | ||
| 04.11. | Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset | ||
| 04.11. | Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3 | ||
| 03.11. | Pharma's corporate reputation dips among neurology patient groups, citing drug access challenges | ||
| 03.11. | Kimberly-Clark buys out Kenvue in $48.7B consumer health merger | ||
| 03.11. | Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win | ||
| 03.11. | CDER chief George Tidmarsh resigns as deleted LinkedIn post prompts Aurinia lawsuit, FDA probe |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .